Generation and properties of a new human ventral mesencephalic neural stem cell line

Experimental Cell Research

Volumn 315, Issue 11, 2009, Pages 1860-1874

  Villa, Ana ^a   Liste, Isabel ^a   Courtois, Elise T ^a   Seiz, Emma G ^a   Ramos, Milagros ^a   Meyer, Morten ^b   Juliusson, Bengt ^c   Kusk, Philip ^c   Martínez Serrano, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c NsGene AS   (Denmark)

Author keywords

Dopaminergic neurons; Human neural stem cells; Immortalization; Parkinson's disease; Ventral mesencephalon

Indexed keywords

DOPAMINE; NESTIN; NEUROGENIN 2; ONCOPROTEIN; TRANSCRIPTION FACTOR MASH1; VIMENTIN;

ARTICLE; ASTROCYTE; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FETUS; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TARGET CELL;

EID: 67349231164     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.03.011     Document Type: Article

References (59)

1. Le Belle J.E., and Svendsen C.N. Stem cells for neurodegenerative disorders: where can we go from here?. BioDrugs 16 (2002) 389-401
2. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10 (2004) S42-50 (Suppl.)
3. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat. Biotechnol. 23 (2005) 862-871
4. Lindvall O., and Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 441 (2006) 1094-1096
5. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., and Perl D.P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease,. New England J. Med. 332 (1995) 1118-1124
6. Piccini P., Brooks D.J., Bjorklund A., Gunn R.N., Grasby P.M., Rimoldi O., Brundin P., Hagell P., Rehncrona S., Widner H., and Lindvall O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. 2 (1999) 1137-1140
7. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., and Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New England J. Med. 344 (2001) 710-719
8. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., and Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54 (2003) 403-414
9. Winkler C., Kirik D., and Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 28 (2005) 86-92
10. Arenas E. Stem cells in the treatment of Parkinson's disease. Brain Res. Bull. 57 (2002) 795-808
11. Snyder B.J., and Olanow C.W. Stem cell treatment for Parkinson's disease: an update for 2005. Curr. Opinion Neurobiol. 18 (2005) 376-385
12. Parish C.L., and Arenas E. Stem-cell-based strategies for the treatment of Parkinson's disease. Neurobiol. Dis. 4 (2007) 339-347
13. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., and Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12543-12548
14. Park C.H., Minn Y.H., Lee J.Y., Choi D.H., Chang M.Y., Shim J.W., Ko J.Y., Koh H.C., Kang M.J., Kang J.S., Rhie D.J., Lee Y.S., Son H., Moon S.Y., Kim K.S., and Lee S.H. In vitro and in vivo analysis of human embryonic stem cell-derived dopamine neurons. J. Neurochem. 92 (2005) 1265-1276
15. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., Morizane A., Bergquist F., Rieibe I., Nannmark U., Carta M., Hanse E., Takahashi J., Sasai Y., Funa K., Brundin P., Eriksson P.S., and Li J.Y. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24 (2006) 1433-1440
16. Roy N., Cleren C., Singh S.K., Yang L., Beal M.F., and Goldman S. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12 (2006) 1259-1268
17. Sonntag K.C., Pruszak J., Yoshizaki T., van Arensbergen J., Sanchez-Pernaute R., and Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using bone morphogenic protein antagonist noggin. Stem Cells 25 (2007) 411-418
18. Studer L., Tabar V., and McKay R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1 (1998) 290-295
19. Potter E.D., Ling Z.D., and Carvey P.M. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res. 296 (1999) 235-246
20. Studer L., Csete M., Lee S.H., Kabbani N., Walikonis J., Wold B., and McKay R. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20 (2000) 7377-7383
21. Storch A., Paul G., Csete M., Boehm B.O., Carvey P.M., Kupsch A., and Schwarz J. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170 (2001) 317-325
22. Liste I., Garcia-Garcia E., and Martinez-Serrano A. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J. Neurosci. 24 (2004) 10786-10795
23. Vergano-Vera E., Yusta-Boyo M.J., de Castro F., Bernard A., de Pablo F., and Vicario-Abejon C. Generation of GABAergic and dopaminergic interneurons from endogenous embryonic olfactory bulb precursor cells. Development 133 (2006) 4367-4379
24. Carpenter M.K., Cui X., Hu Z.Y., Jackson J., Sherman S., Seiger A., and Wahlberg L.U. In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neurol. 158 (1999) 265-278
25. Vescovi A.L., Parati E.A., Gritti A., Poulin P., Ferrario M., Wanke E., Frolichsthal-Schoeller P., Cova L., Arcellana-Panlilio M., Colombo A., and Galli R. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol. 156 (1999) 71-83
26. Martinez-Serrano A., Rubio F.J., Navarro B., Bueno C., and Villa A. Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr. Gene Ther. 1 (2001) 279-299
27. Palmer T.D., Schwartz P.H., Taupin P., Kaspar B., Stein S.A., and Gage F.H. Cell culture. Progenitor cells from human brain after death. Nature 411 (2001) 42-43
28. Jakel R.J., Schneider B.L., and Svendsen C.N. Using human neural stem cells to model neurological disease. Nat. Rev. Genet. 5 (2004) 136-144
29. Sah D.W., Ray J., and Gage F.H. Regulation of voltage- and ligand-gated currents in rat hippocampal progenitor cells in vitro. J. Neurobiol. 32 (1997) 95-110
30. Truckenmiller M.E., Tornatore C., Wright R.D., Dillon-Carter O., Meiners S., Geller H.M., and Freed W.J. A truncated SV40 large T antigen lacking the p53 binding domain overcomes p53-induced growth arrest and immortalizes primary mesencephalic cells. Cell Tissue Res. 291 (1998) 175-189
31. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., and Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277 (2002) 38884-38894
32. Paul G., Christophersen N.S., Raymon H., Kiaer C., Smith R., and Brundin P. Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line-studies in vitro and after intracerebral grafting in vivo. Mol. Cell. Neurosci. 34 (2007) 390-399
33. Roy N.S., Chandler-Militello D., Lu G., Wang S., and Goldman S.A. Retrovirally mediated telomerase immortalization of neural progenitor cells. Nat. Protoc. 2 (2007) 2815-2825
34. Flax J.D., Aurora S., Yang C., Simonin C., Wills A.M., Billinghurst L.L., Jendoubi M., Sidman R.L., Wolfe J.H., Kim S.U., and Snyder E.Y. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16 (1998) 1033-1039
35. Villa A., Snyder E.Y., Vescovi A., and Martinez-Serrano A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp. Neurol 161 (2000) 67-84
36. Cacci E., Villa A., Parmar M., Cavallaro M., Mandahl N., Lindvall O., Martinez-Serrano A., and Kokaia Z. Generation of human cortical neurons from a new immortal fetal neural stem cell line. Exp. Cell. Res. 313 (2007) 588-601
37. Khan Z., Akhtar M., Asklund T., Juliusson B., Almquist P.M., and Ekström T.J. HDAC inhibition amplifies gap junction communication in neural progenitors: potential for cell-mediated enzyme prodrug therapy. Exp. Cell. Res. 313 (2007) 2958-2967
38. Donato R., Miljan E.A., Hines S.J., Aouabdi S., Pollock K., Patel S., Edwards F., and Sinden J.D. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 8 (2007) 36
39. Liste I., Villa A., Bueno C., Juliusson B., Kusk P., Courtois E., and Martinez-Serrano A. Bcl-XL enhances the neurogenic capacity and dopamine neuron production by human ventral mesencephalic neural stem/precursor cells. Society Neurosci. Abstr. (2004) No 825.10.
40. Courtois E., Ramos M., Villa A., Liste I., Bueno C., Juliusson B., Kusk P., and Martinez-Serrano A. Bcl-XL enhances the survival of human fetal ventral mesencephalic stem cells in vitro and the yield of dopaminergic human neurons. Society. Neurosci. Abstr. (2005) No 479.18.
41. Liste I., Garcia-Garcia E., Bueno C., and Martinez-Serrano A. Bcl-XL modulates the differentiation of immortalized human neural stem cells. Cell Death Diff. 14 (2007) 1880-1892
42. Riaz S.S., Jauniaux E., Stern G.M., and Bradford H.F. The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro. Brain Res. 136 (2002) 27-34
43. Jensen P., Bauer M., Jensen C.H., Widmer H.R., Gramsbergen J.B., Blaabjerg M., Zimmer J., and Meyer M. Expansion and characterization of ventral mesencephalic precursor cells: effect of mitogens and investigation of FA1 as a potential dopaminergic marker. J. Neurosci. Res 85 (2007) 1884-1893
44. Nolan T., Hands R.E., and Bustin S.A. Quantification of mRNA using real time RT-PCR. Nat. Protocol. 3 (2006) 1561-1582
45. Navarro B., Villa A., Liste I., Bueno C., and Martinez-Serrano A. Isolation, proliferation, survival and differentiation of human neural stem/precursor cells in vitro and in vivo. A focus on their potential clinical applications. In: Bottenstein J.E. (Ed). Neural Stem Cells: Development and Transplantation (2003), Kluwer Academic Publisher, Dordrecht 271-298
46. Navarro-Galve B., and Martinez-Serrano A. "Is there ay need to argue..." about the nature and genetic signature of in vitro neural stem cells?,. Exp. Neurol. 199 (2006) 20-25
47. Hall A.C., Mira H., Wagner J., and Arenas E. Region-specific effects of glia on neuronal induction and differentiation with a focus on dopaminergic neurons. Glia 43 (2003) 47-51
48. Kele J., Simplicio N., Ferri A., Mira H., Guillemot F., Arenas E., and Ang S.L. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133 (2006) 495-505
49. Andersson E., Jensen J.B., Parmar M., Guillemot F., and Bjorklund A. Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development 133 (2006) 507-516
50. Isaacs K.R., and Jacobowitz D.M. Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area. Exp. Brain Res. 99 (1994) 34-42
51. Roybon L., Hjalt T., Christophersen N.S., Li J.Y., and Brundin P. Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3,. J. Neurosci. 28 (2008) 3644-3656
52. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
53. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., and Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2883-2888
54. Cartwright P., Mclean C., Sheppard A., Rivett D., Jones K., and Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a myc-dependent mechanism. Development 132 (2005) 885-896
55. De Filippis L., Lamorte G., Snyder E.Y., Malgaroli A., and Vescovi A.L. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells 25 (2007) 2312-2321
56. Navarro-Galve B., Villa A., Bueno C., Thompson L., Johansen J., and Martinez-Serrano A. Gene marking of human neural stem/precursor cells using green fluorescent proteins. J. Gene Med. 7 (2005) 18-29
57. Alavian K.N., Scholz C., and Simon H. Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Mov. Dis. 23 (2007) 319-328
58. Olanow C.W., Kordower J.H., and Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19 (1996) 102-109
59. Wagner J., Akerud P., Castro D.C., Holm P.C., Canals J.M., Snyder E., Perlmann T., and Arenas E. Induction of midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by astrocytes. Nat. Biotechnol. 17 (1999) 653-659